Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients-Reference-Cited by-同舟云学术

Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients

Published:2017-01-09 Issue:1 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hahn Deirdre¹,Esezobor Christopher I²,Elserafy Noha¹,Webster Angela C³⁴⁵,Hodson Elisabeth M³⁵

Affiliation:

1. The Children's Hospital at Westmead; Department of Nephrology; Locked Bag 4001 Westmead NSW Australia 2145

2. College of Medicine, University of Lagos; Department of Paediatrics; Lagos University Teaching Hospital Lagos Lagos Nigeria 101014

3. The University of Sydney; Sydney School of Public Health; Edward Ford Building A27 Sydney NSW Australia 2006

4. The University of Sydney at Westmead; Centre for Transplant and Renal Research, Westmead Millennium Institute; Westmead NSW Australia 2145

5. The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145

Publisher

Wiley

Subject

Pharmacology (medical)

Reference96 articles.

1. Comparison of efficacy of subcutaneous versus intravenous erythropoeitin in anaemia of chronic renal failure [abstract no: 227];Aggarwal;Journal of the Association of Physicians of India,2001

2. Comparative efficacy of subcutaneous versus intravenous dose of erythropoietin in pre-dialysis patients of chronic renal failure;Aggarwal;Journal of Indian Academy of Clinical Medicine,2002

3. Randomized double-blind study of subcutaneous recombinant human erythropoietin in predialysis uraemic patients [abstract];Akiba;Nephrology Dialysis Transplantation,1992

4. Amon O Muller-Wiefel DE Daniel K Eife R Leititis J Stolpe HJ Is S.C. erythropoietin (rhEPO) treatment thrice per week superior to an application once per week? [abstract] 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 - Sep 4; Jerusalem, Israel 1992 C143

5. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients;Frenken;Nephrology Dialysis Transplantation,1989

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse events of iron and/or erythropoiesis-stimulating agent therapy in preoperatively anemic elective surgery patients: a systematic review;Systematic Reviews;2022-10-17

2. Anemia in elderly women. Rational prevention. Evidence base;Meditsinskiy sovet = Medical Council;2021-04-15

3. Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents;Frontiers in Medicine;2021-03-26

4. Erythropoietin Administration for Anemia Due to Chronic Kidney Disease - Subcutaneous OR Intravenous, What Do We Know So Far?;Cureus;2020-09-10

5. Long- or short-acting erythropoiesis-stimulating agents: take no shortcuts in their evaluation;Nephrology Dialysis Transplantation;2020-06-24